adient - ADNT
ADNT
Close Chg Chg %
19.08 0.23 1.18%
Closed Market
19.31
+0.23 (1.18%)
Volume: 1.15M
Last Updated:
Nov 22, 2024, 3:59 PM EDT
Company Overview: adient - ADNT
ADNT Key Data
| Open $19.28 | Day Range 19.17 - 19.63 |
| 52 Week Range 18.54 - 37.19 | Market Cap $1.62B |
| Shares Outstanding 84.87M | Public Float 82.97M |
| Beta 2.18 | Rev. Per Employee N/A |
| P/E Ratio 95.55 | EPS $0.24 |
| Yield 0.00% | Dividend $0.28 |
| EX-DIVIDEND DATE Oct 23, 2018 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.29M |
ADNT Performance
| 1 Week | -2.77% | ||
| 1 Month | -7.42% | ||
| 3 Months | -11.28% | ||
| 1 Year | -40.49% | ||
| 5 Years | -9.88% |
ADNT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
13
Full Ratings ➔
About adient - ADNT
Adient plc designs, manufactures, and markets automotive seating systems. It operates through the following geographical segments: Americas, EMEA, and Asia. The company was founded in 1985 and is headquartered in Plymouth, MI.
ADNT At a Glance
Adient plc
49200 Halyard Drive
Plymouth, Michigan 48170
| Phone | 1-734-254-5000 | Revenue | 14.69B | |
| Industry | Auto Parts: OEM | Net Income | 18.00M | |
| Sector | Producer Manufacturing | Employees | 70,000 | |
| Fiscal Year-end | 09 / 2025 | |||
| View SEC Filings |
ADNT Valuation
| P/E Current | 95.546 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 112.963 |
| Price to Sales Ratio | 0.138 |
| Price to Book Ratio | 0.898 |
| Price to Cash Flow Ratio | 3.78 |
| Enterprise Value to EBITDA | 5.233 |
| Enterprise Value to Sales | 0.282 |
| Total Debt to Enterprise Value | 0.64 |
ADNT Efficiency
| Revenue/Employee | 209,828.571 |
| Income Per Employee | 257.143 |
| Receivables Turnover | 7.747 |
| Total Asset Turnover | 1.565 |
ADNT Liquidity
| Current Ratio | 1.111 |
| Quick Ratio | 0.905 |
| Cash Ratio | 0.257 |
ADNT Profitability
| Gross Margin | 6.577 |
| Operating Margin | 3.125 |
| Pretax Margin | 0.906 |
| Net Margin | 0.123 |
| Return on Assets | 0.192 |
| Return on Equity | 0.825 |
| Return on Total Capital | 0.376 |
| Return on Invested Capital | 0.379 |
ADNT Capital Structure
| Total Debt to Total Equity | 124.227 |
| Total Debt to Total Capital | 55.402 |
| Total Debt to Total Assets | 28.35 |
| Long-Term Debt to Equity | 120.15 |
| Long-Term Debt to Total Capital | 53.584 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Adient - ADNT
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 13.68B | 14.12B | 15.39B | 14.69B | |
Sales Growth
| +7.97% | +3.22% | +9.02% | -4.59% | |
Cost of Goods Sold (COGS) incl D&A
| 12.85B | 13.32B | 14.42B | 13.72B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 330.00M | 350.00M | 340.00M | 332.00M | |
Depreciation
| 285.00M | 298.00M | 290.00M | 285.00M | |
Amortization of Intangibles
| 45.00M | 52.00M | 50.00M | 47.00M | |
COGS Growth
| +6.58% | +3.64% | +8.26% | -4.84% | |
Gross Income
| 828.00M | 801.00M | 975.00M | 966.00M | |
Gross Income Growth
| +35.29% | -3.26% | +21.72% | -0.92% | |
Gross Profit Margin
| +6.05% | +5.67% | +6.33% | +6.58% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 518.00M | 589.00M | 549.00M | 507.00M | |
Research & Development
| 316.00M | 322.00M | 362.00M | 372.00M | |
Other SG&A
| 202.00M | 267.00M | 187.00M | 135.00M | |
SGA Growth
| -4.60% | +13.71% | -6.79% | -7.65% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 74.00M | 67.00M | 63.00M | 138.00M | |
EBIT after Unusual Expense
| 236.00M | 145.00M | 363.00M | 321.00M | |
Non Operating Income/Expense
| 1.46B | 97.00M | 135.00M | 44.00M | |
Non-Operating Interest Income
| 7.00M | 9.00M | 22.00M | 28.00M | |
Equity in Earnings of Affiliates
| 1.48B | 75.00M | 84.00M | 90.00M | |
Interest Expense
| 258.00M | 188.00M | 203.00M | 232.00M | |
Interest Expense Growth
| +9.79% | -27.13% | +7.98% | +14.29% | |
Gross Interest Expense
| 258.00M | 188.00M | 203.00M | 232.00M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 1.44B | 54.00M | 295.00M | 133.00M | |
Pretax Income Growth
| +435.43% | -96.25% | +446.30% | -54.92% | |
Pretax Margin
| +10.52% | +0.38% | +1.92% | +0.91% | |
Income Tax
| - | 249.00M | 94.00M | 32.00M | |
Income Tax - Current - Domestic
| 1.00M | 6.00M | 4.00M | 5.00M | |
Income Tax - Current - Foreign
| 208.00M | 83.00M | 120.00M | 28.00M | |
Income Tax - Deferred - Domestic
| - | (1.00M) | (1.00M) | 1.00M | |
Income Tax - Deferred - Foreign
| 41.00M | 6.00M | (125.00M) | (1.00M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| 1.48B | 75.00M | 84.00M | 90.00M | |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 1.19B | (40.00M) | 295.00M | 101.00M | |
Minority Interest Expense
| 82.00M | 80.00M | 90.00M | 83.00M | |
Net Income
| 1.11B | (120.00M) | 205.00M | 18.00M | |
Net Income Growth
| +302.56% | -110.83% | +270.83% | -91.22% | |
Net Margin Growth
| +8.10% | -0.85% | +1.33% | +0.12% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 1.11B | (120.00M) | 205.00M | 18.00M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 1.11B | (120.00M) | 205.00M | 18.00M | |
EPS (Basic)
| 11.7622 | -1.2658 | 2.1693 | 0.2011 | |
EPS (Basic) Growth
| +301.70% | -110.76% | +271.38% | -90.73% | |
Basic Shares Outstanding
| 94.20M | 94.80M | 94.50M | 89.50M | |
EPS (Diluted)
| 11.5778 | -1.2658 | 2.1488 | 0.1998 | |
EPS (Diluted) Growth
| +298.54% | -110.93% | +269.76% | -90.70% | |
Diluted Shares Outstanding
| 95.70M | 94.80M | 95.40M | 90.10M | |
EBITDA
| 640.00M | 562.00M | 766.00M | 791.00M | |
EBITDA Growth
| +59.60% | -12.19% | +36.30% | +3.26% | |
EBITDA Margin
| +4.68% | +3.98% | +4.98% | +5.39% |
Snapshot
| Average Recommendation | HOLD | Average Target Price | 25.556 | |
| Number of Ratings | 13 | Current Quarters Estimate | 0.336 | |
| FY Report Date | 12 / 2024 | Current Year's Estimate | 1.994 | |
| Last Quarter’s Earnings | 0.68 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.84 | Next Fiscal Year Estimate | 2.973 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 7 | 8 | 10 | 9 |
| Mean Estimate | 0.34 | 0.39 | 1.99 | 2.97 |
| High Estimates | 0.48 | 0.57 | 2.41 | 4.00 |
| Low Estimate | 0.21 | 0.25 | 1.54 | 1.92 |
| Coefficient of Variance | 27.97 | 26.81 | 11.81 | 22.20 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 3 | 4 | 5 |
| OVERWEIGHT | 1 | 1 | 0 |
| HOLD | 7 | 6 | 5 |
| UNDERWEIGHT | 1 | 1 | 1 |
| SELL | 1 | 1 | 1 |
| MEAN | Hold | Hold | Overweight |
SEC Filings for Adient - ADNT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Adient - ADNT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| May 17, 2024 | Gregory Scott Smith SVP & Chief Accounting Officer | 15,399 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $29.47 per share | 453,808.53 |
| May 10, 2024 | Peter Harold Carlin Director | 28,352 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $28.9 per share | 819,372.80 |
| Mar 15, 2024 | Frederick Arthur Henderson Director | 76,135 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 15, 2024 | Ricky T. Dillon Director | 14,643 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 15, 2024 | Richard A. A. Goodman Director | 40,659 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 15, 2024 | Barbara Jean Samardzich Director | 40,270 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 15, 2024 | José M. Gutiérrez Director | 37,023 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 15, 2024 | Julie L. Bushman Director | 41,340 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 15, 2024 | Jodi Eddy Director | 6,225 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 22, 2024 | Michel Pierre Rose Berthelin EVP, EMEA | 92,662 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $34.22 per share | 3,170,893.64 |
| Feb 16, 2024 | Heather M. Tiltmann EVP, CLO, CHRO & Secretary | 55,669 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $33.68 per share | 1,874,931.92 |
| Feb 14, 2024 | Jim Conklin EVP, Americas | 31,542 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $35 per share | 1,103,970.00 |
| Feb 13, 2024 | Mark A. Oswald EVP and CFO | 28,649 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Feb 13, 2024 | Mark A. Oswald EVP and CFO | 28,504 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $33.62 per share | 958,304.48 |
| Feb 13, 2024 | Jerome Dorlack President and CEO; Director | 251,051 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |